Market Cap ₹18321 Cr.
Stock P/E 30.3
P/B 19.3
Current Price ₹7955.1
Book Value ₹ 411.2
Face Value 10
52W High ₹9370.4
Dividend Yield 2.1%
52W Low ₹ 5754.3
Sanofi India Ltd manufactures and trades in capsules and pharmaceutical products in India, Singapore and internationally. It presents pharmaceutical merchandise in diverse therapeutic areas, which include diabetes, cardiology, thrombosis, critical nervous machine, anti-infective, epilepsy, hypersensitive reaction and vitamins, anti-histamines, and minerals and supplements underneath the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands thru independent distributors. The business enterprise additionally exports its products. The organisation was formerly called Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Ltd is a subsidiary of Hoechst GmbH.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|
| Net Sales | 706 | 715 | 694 |
| Other Income | 16 | 12 | 12 |
| Total Income | 722 | 726 | 706 |
| Total Expenditure | 528 | 506 | 507 |
| Operating Profit | 194 | 220 | 199 |
| Interest | 1 | 0 | 0 |
| Depreciation | 10 | 10 | 10 |
| Exceptional Income / Expenses | 0 | 0 | 0 |
| Profit Before Tax | 183 | 210 | 189 |
| Provision for Tax | 61 | 58 | 51 |
| Profit After Tax | 123 | 152 | 138 |
| Adjustments | 0 | 0 | 0 |
| Profit After Adjustments | 123 | 152 | 138 |
| Adjusted Earnings Per Share | 53.4 | 66 | 59.9 |
| #(Fig in Cr.) | Dec 2023 | TTM |
|---|---|---|
| Net Sales | 2851 | 2115 |
| Other Income | 67 | 40 |
| Total Income | 2918 | 2154 |
| Total Expenditure | 2049 | 1541 |
| Operating Profit | 869 | 613 |
| Interest | 2 | 1 |
| Depreciation | 40 | 30 |
| Exceptional Income / Expenses | 18 | 0 |
| Profit Before Tax | 846 | 582 |
| Provision for Tax | 243 | 170 |
| Profit After Tax | 603 | 413 |
| Adjustments | 0 | 0 |
| Profit After Adjustments | 603 | 413 |
| Adjusted Earnings Per Share | 262.1 | 179.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 40% | 1% | 8% | 10% |
| ROE Average | 87% | 87% | 87% | 87% |
| ROCE Average | 115% | 115% | 115% | 115% |
| #(Fig in Cr.) | Dec 2023 |
|---|---|
| Shareholder's Funds | 1015 |
| Minority's Interest | 0 |
| Borrowings | 0 |
| Other Non-Current Liabilities | 1153 |
| Total Current Liabilities | 2535 |
| Total Liabilities | 4703 |
| Fixed Assets | 315 |
| Other Non-Current Assets | 1257 |
| Total Current Assets | 3131 |
| Total Assets | 4703 |
| #(Fig in Cr.) | Dec 2023 |
|---|---|
| Opening Cash & Cash Equivalents | 1005 |
| Cash Flow from Operating Activities | 230 |
| Cash Flow from Investing Activities | 38 |
| Cash Flow from Financing Activities | -878 |
| Net Cash Inflow / Outflow | -610 |
| Closing Cash & Cash Equivalent | 395 |
| # | Dec 2023 |
|---|---|
| Earnings Per Share (Rs) | 262.13 |
| CEPS(Rs) | 279.35 |
| DPS(Rs) | 167 |
| Book NAV/Share(Rs) | 411.7 |
| Core EBITDA Margin(%) | 27.07 |
| EBIT Margin(%) | 28.58 |
| Pre Tax Margin(%) | 28.52 |
| PAT Margin (%) | 20.34 |
| Cash Profit Margin (%) | 21.68 |
| ROA(%) | 22.71 |
| ROE(%) | 87.18 |
| ROCE(%) | 115.15 |
| Receivable days | 13.83 |
| Inventory Days | 47.71 |
| Payable days | 50.43 |
| PER(x) | 30.78 |
| Price/Book(x) | 19.59 |
| Dividend Yield(%) | 2.07 |
| EV/Net Sales(x) | 6.37 |
| EV/Core EBITDA(x) | 20.88 |
| Net Sales Growth(%) | 283.87 |
| EBIT Growth(%) | 254.32 |
| PAT Growth(%) | 286.6 |
| EPS Growth(%) | 287.11 |
| Debt/Equity(x) | 0 |
| Current Ratio(x) | 1.24 |
| Quick Ratio(x) | 0.97 |
| Interest Cover(x) | 498.35 |
| Total Debt/Mcap(x) | 0 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 60.4 | 60.4 | 60.4 | 60.4 | 60.4 | 60.4 | 60.4 | 60.4 | 60.4 | 60.4 |
| FII | 9.22 | 8.99 | 8.71 | 8.26 | 6.99 | 6.71 | 6.72 | 6.8 | 6.31 | 6.11 |
| DII | 19.05 | 18.65 | 18.59 | 18.28 | 19.21 | 19.46 | 19.66 | 21.69 | 22.51 | 22.88 |
| Public | 11.33 | 11.96 | 12.3 | 13.07 | 13.4 | 13.43 | 13.22 | 11.11 | 10.78 | 10.61 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 |
| FII | 0.21 | 0.21 | 0.2 | 0.19 | 0.16 | 0.15 | 0.15 | 0.16 | 0.15 | 0.14 |
| DII | 0.44 | 0.43 | 0.43 | 0.42 | 0.44 | 0.45 | 0.45 | 0.5 | 0.52 | 0.53 |
| Public | 0.26 | 0.28 | 0.28 | 0.3 | 0.31 | 0.31 | 0.3 | 0.26 | 0.25 | 0.24 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
